Prevymis (letermovir) - Merck (MSD)
Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Short Telomere Pulmonary Fibrosis Lung Transplant Recipients (ATS 2026) - Mar 3, 2026 - Pres time: May 19, 2026; 11:30 AM - 01:15 PM; Location: TP23; No abstract available 
Clinical • Cytomegalovirus Infection • Immunology • Pulmonary Disease • Respiratory Diseases • Transplantation
https://ats2026.d365.events/education/abstracts/abstracts/ff8657a3-59fb-4299-b400-fc17d40ec5fe
 
Ritchie Koshy, MD; Rachel Sutton, MS; Chadi A. Hage, MD, ATSF; Stefanie Hannan, CRNP; John F. Mcdyer, MD; Carlo Iasella, PharmD; Jonathan K. Alder, PhD
 
Mar 3, 2026
 
Prev Next